Ovid Therapeutics (OVID) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced at 10:30 A.M. on June 10, 2026, via a virtual platform, with introductions of key executives and auditors.

• The agenda included three proposals: election of a director, advisory vote on executive compensation, and ratification of the auditor.

• Voting procedures and meeting conduct rules were explained, with polls opened for voting.

Board and executive committee updates

• Jeremy M. Levin was nominated for election as Class III director to serve until the 2029 annual meeting.

Shareholder proposals

• Three proposals were presented: election of a director, advisory approval of executive compensation, and ratification of KPMG as auditor for 2026.